Warisawa Takayuki, Sonoda Shinjo, Yamaji Kyohei, Amano Tetsuya, Kohsaka Shun, Natsuaki Masahiro, Tsujita Kenichi, Hibi Kiyoshi, Kobayashi Yoshio, Kozuma Ken
Department of Cardiology, NTT Medical Center Tokyo, Tokyo, Japan.
Department of Cardiovascular Medicine, Saga University, 5-1-1, Nabeshima, Saga, 849-8501, Japan.
Cardiovasc Interv Ther. 2024 Oct;39(4):386-402. doi: 10.1007/s12928-024-01030-4. Epub 2024 Jul 30.
Percutaneous coronary intervention for left main coronary artery disease (LM-PCI) represents a high-risk yet life-saving procedure that has evolved significantly over the years. This review outlines the current state-of-the-art practices for LM-PCI in Japan in detail, emphasizing the integration of coronary physiology and intracoronary imaging alongside with evidence-based standardized technique using latest drug-eluting stents. These advancements enable precise lesion assessment, stent sizing, and optimal deployment, thereby enhancing procedural safety and efficacy. Despite discrepancies between current guidelines favoring coronary artery bypass grafting and real-world practice trends towards increased LM-PCI adoption, particularly in elderly populations with multiple comorbidities, careful patient selection and procedural planning are critical. Future perspectives include further refining LM-PCI through conducting randomized controlled trials integrating advanced techniques and addressing the issue of ostial left circumflex lesions and nationwide standardization of medical care for LM disease.
经皮冠状动脉介入治疗左主干冠状动脉疾病(LM-PCI)是一种高风险但能挽救生命的手术,多年来已取得显著进展。本综述详细概述了日本目前LM-PCI的先进技术,强调冠状动脉生理学和血管内成像与使用最新药物洗脱支架的循证标准化技术的整合。这些进展能够实现精确的病变评估、支架尺寸选择和最佳置入,从而提高手术的安全性和有效性。尽管目前的指南倾向于冠状动脉旁路移植术,而现实世界中LM-PCI的应用趋势有所增加,尤其是在患有多种合并症的老年人群中,但仔细的患者选择和手术规划至关重要。未来的展望包括通过开展整合先进技术的随机对照试验,进一步完善LM-PCI,解决左旋支开口病变问题,并在全国范围内实现LM疾病医疗护理的标准化。